Literature DB >> 18607541

Synthesis and antiproliferative activity of substituted diazaspiro hydantoins: a structure-activity relationship study.

C S Ananda Kumar1, S B Benaka Prasad, K Vinaya, S Chandrappa, N R Thimmegowda, S R Ranganatha, Sanjay Swarup, K S Rangappa.   

Abstract

In the course of structure-activity relationship studies and to explore the antiproliferative effect associated with the hydantoin framework, diversely substituted several diazaspiro hydantoins were synthesized. Variation in the functional group at N-terminal of the hydantoin ring and coupling of different substituted aromatic acids in 4-aminocyclohexanone ring led to three sets of compounds. The antiproliferative effect of the compounds was evaluated in vitro using the MTT colorimetric method against one normal cell line (NDF-103 skin fibroblast cells) and four human cancer cell lines (MCF-7 breast carcinoma cell line, HepG-2 hepatocellular carcinoma cell line, HeLa cervix carcinoma cell line and HT-29 colon carcinoma cell line) for the time period of 24 h. Among the series, some compounds exhibited interesting growth inhibitory effects against all four cell lines. From the SAR studies, it reveals that, the substitution at N-terminal in hydantoin ring plays key role in the antiproliferative activity.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18607541     DOI: 10.1007/s10637-008-9150-3

Source DB:  PubMed          Journal:  Invest New Drugs        ISSN: 0167-6997            Impact factor:   3.850


  28 in total

Review 1.  Novel anticancer targets and drug discovery in post genomic age.

Authors:  Qianbin Li; Wenfang Xu
Journal:  Curr Med Chem Anticancer Agents       Date:  2005-01

2.  Sodium channel binding and anticonvulsant activities of hydantoins containing conformationally constrained 5-phenyl substituents.

Authors:  W J Brouillette; G B Brown; T M DeLorey; G Liang
Journal:  J Pharm Sci       Date:  1990-10       Impact factor: 3.534

3.  A novel series of 2,5-substituted tryptamine derivatives as vascular 5HT1B/1D receptor antagonists.

Authors:  G P Moloney; A D Robertson; G R Martin; S MacLennan; N Mathews; S Dodsworth; P Y Sang; C Knight; R Glen
Journal:  J Med Chem       Date:  1997-07-18       Impact factor: 7.446

Review 4.  Advances in the medical treatment of epilepsy.

Authors:  C W Bazil; T A Pedley
Journal:  Annu Rev Med       Date:  1998       Impact factor: 13.739

5.  Hydantoin derivative formation from oxidation of 7,8-dihydro-8-oxo-2'-deoxyguanosine (8-oxodG) and incorporation of 14C-labeled 8-oxodG into the DNA of human breast cancer cells.

Authors:  Sang Soo Hah; Hyung M Kim; Rhoda A Sumbad; Paul T Henderson
Journal:  Bioorg Med Chem Lett       Date:  2005-08-01       Impact factor: 2.823

6.  Structural and electronic conditions for anticonvulsant activity of bicyclic hydantoin derivatives.

Authors:  J Karolak-Wojciechowska; W Kwiatkowski; K Kiec-Kononowicz
Journal:  Pharmazie       Date:  1995-02       Impact factor: 1.267

7.  Bicyclic hydantoins with a bridgehead nitrogen. Comparison of anticonvulsant activities with binding to the neuronal voltage-dependent sodium channel.

Authors:  W J Brouillette; V P Jestkov; M L Brown; M S Akhtar; T M DeLorey; G B Brown
Journal:  J Med Chem       Date:  1994-09-30       Impact factor: 7.446

8.  Anticonvulsant activity of phenylmethylenehydantoins: a structure-activity relationship study.

Authors:  Jeyanthi Chinnappa Thenmozhiyal; Peter Tsun-Hon Wong; Wai-Keung Chui
Journal:  J Med Chem       Date:  2004-03-11       Impact factor: 7.446

Review 9.  Targeted cancer therapy.

Authors:  Charles Sawyers
Journal:  Nature       Date:  2004-11-18       Impact factor: 49.962

10.  Hydantoin-substituted 4,6-dichloroindole-2-carboxylic acids as ligands with high affinity for the glycine binding site of the NMDA receptor.

Authors:  Michaela Jansen; Heidrun Potschka; Claudia Brandt; Wolfgang Löscher; Gerd Dannhardt
Journal:  J Med Chem       Date:  2003-01-02       Impact factor: 7.446

View more
  4 in total

1.  Synthesis and in vitro cytotoxic evaluation of novel diazaspiro bicyclo hydantoin derivatives in human leukemia cells: a SAR study.

Authors:  C S Ananda Kumar; C V Kavitha; K Vinaya; S B Benaka Prasad; N R Thimmegowda; S Chandrappa; Sathees C Raghavan; K S Rangappa
Journal:  Invest New Drugs       Date:  2008-10-07       Impact factor: 3.850

2.  Synthesis and identification of a new class of (S)-2,6-diamino-4,5,6,7-tetrahydrobenzo[d]thiazole derivatives as potent antileukemic agents.

Authors:  D S Prasanna; C V Kavitha; B Raghava; K Vinaya; S R Ranganatha; Sathees C Raghavan; K S Rangappa
Journal:  Invest New Drugs       Date:  2009-06-10       Impact factor: 3.850

3.  Synthesis of novel 6-fluoro-3-(4-piperidinyl)-1,2-benzisoxazole derivatives as antiproliferative agents: a structure-activity relationship study.

Authors:  S B Benaka Prasad; K Vinaya; C S Ananda Kumar; Sanjay Swarup; K S Rangappa
Journal:  Invest New Drugs       Date:  2008-12-06       Impact factor: 3.850

4.  Antiproliferative and antimigratory effects of 3-(4-substituted benzyl)-5- isopropyl-5-phenylhydantoin derivatives in human breast cancer cells.

Authors:  Ana Obradović; Miloš Matić; Branka Ognjanović; Predrag Đurđević; Emilija Marinković; Gordana Ušćumlić; Bojan Božić; Biljana Božić Nedeljković
Journal:  Saudi Pharm J       Date:  2020-01-24       Impact factor: 4.330

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.